24.06.2023 |
Scientific publications

Coagulation assays for assessing direct FXa inhibitor oral anticoagulant reversal effect

Factor Xa direct oral anticoagulants (Fxa-DOACs) require rapid reversal in patients with serious bleeding or prior to urgent surgery.

Related items

24.06.2023

Scientific publications

Coagulation assays for assessing direct FXa inhibitor oral anticoagulant reversal effect
Factor Xa direct oral anticoagulants (Fxa-DOACs) require rapid reversal in patients with serious bleeding or prior to urgent surgery.
Read more

09.07.2022

Scientific publications

Preclinical safety and toxicokinetics of VMX-C001 – an intravenous bypassing agent for factor Xa inhibitors
VMX-C001, a modified form of human zymogen factor X, is being developed to stop or prevent bleeding in patients taking…
Read more